Riboxx GmbH, Riboxx, Germany

Tasks in the project:
Riboxx GmbH will contribute to work packages 1,2,4,5 and 6
WP1 : Cell culture-based discovery of antiviral inhibitors and their mechanism of action
WP2 : Antiviral targets in complex with RNA and inhibitors
WP4 : ADME-Tox and validation in animal models
WP5 : Exploitation and route-to-market
WP6 : Coordination

  Human resources

  • Dr Jacques Rohayem, MD/PhD, PI, (M), expertise in molecular virology, viral enzymology, viral models of infection in cell systems and animal models;
  • Dr Christiane Petzold, PhD, Postdoctorate Fellow, (F), expertise in chemical synthesis of RNA, purification of RNA and analysis of RNA;
  • Dr Julia Gebhardt, PhD, Postdoctorate Fellow, (F), expertise in animal models of infection, protein chemistry and cell biology;
  • Mrs. Dorothea Kramer, MSc, PhD-Student, (F), expertise in molecular biology and cell biology;
  • Mrs. Ivonne Robel, BSc, Biotechnologist, (F), expertise in viral enzymology;
  • 2 Postdoctorate fellow to be hired, one with with expertise in analytics of oligonucleotide, i.e. RNA and one with expertise in animal models of infection
  • Dr. Roland Kung (M), Dr. Kathrin Speckl (F), Mrs. J. Wohlfahrt (F), responsible for maintenance of facilities and animals, including monitoring their condition

191 Meissner Strasse,
01 445 Radebeul, Germany.
Tél :0049 (0) 351 4586200. Fax : 0049 (0) 351 833 6010.

The research leading to these results has received funding from the European Union Seventh Programme (FP7 2007/2013) under grant agreement n°260644-SILVER